asimadoline has been researched along with vofopitant in 1 studies
| Studies (asimadoline) | Trials (asimadoline) | Recent Studies (post-2010) (asimadoline) | Studies (vofopitant) | Trials (vofopitant) | Recent Studies (post-2010) (vofopitant) |
|---|---|---|---|---|---|
| 43 | 9 | 11 | 71 | 8 | 12 |
| Protein | Taxonomy | asimadoline (IC50) | vofopitant (IC50) |
|---|---|---|---|
| Substance-P receptor | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, W; Scott, C; Walker, JS | 1 |
1 other study(ies) available for asimadoline and vofopitant
| Article | Year |
|---|---|
Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
Topics: Acetamides; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Progression; Dose-Response Relationship, Drug; Joints; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Pyrrolidines; Rats; Substance P; Tetrazoles | 1999 |